Leech therapeutic applications
Research article published in Indian journal of pharmaceutical sciences (2013)
Abstract
Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding to systemic ailments, such as skin diseases, nervous system abnormalities, urinary and reproductive system problems, inflammation, and dental problems. Recently, extensive researches on leech saliva unveiled the presence of a variety of bioactive peptides and proteins involving antithrombin (hirudin, bufrudin), antiplatelet (calin, saratin), factor Xa inhibitors (lefaxin), antibacterial (theromacin, theromyzin) and others. Consequently, leech has made a comeback as a new remedy for many chronic and life-threatening abnormalities, such as cardiovascular problems, cancer, metastasis, and infectious diseases. In the 20(th) century, leech therapy has established itself in plastic and microsurgery as a protective tool against venous congestion and served to salvage the replanted digits and flaps. Many clinics for plastic surgery all over the world started to use leeches for cosmetic purposes. Despite the efficacious properties of leech therapy, the safety, and complications of leeching are still controversial.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization.
Por qué esto importa para la hirudoterapia
Este artículo de revisión examina las aplicaciones terapéuticas históricas y contemporáneas de las sanguijuelas, catalogando compuestos salivales bioactivos que incluyen antitrombinas (hirudin, bufrudin), agentes antiplaquetarios (calin, saratin), inhibidores del factor Xa (lefaxin) y péptidos antimicrobianos (theromacin, theromyzin), junto con usos clínicos establecidos en cirugía plástica y microcirugía para la congestión venosa. Es directamente relevante para el ámbito de ASH como una revisión general del secretoma salival de la sanguijuela y su potencial traslacional en enfermedades cardiovasculares, oncología y enfermedades infecciosas. La revisión proporciona antecedentes útiles sobre la diversidad de moléculas bioactivas en la saliva de la sanguijuela y la trayectoria histórica de la hirudoterapia, lo que la convierte en una referencia introductoria razonable. Sin embargo, como revisión narrativa, no presenta datos primarios nuevos, análisis cuantitativo ni evaluación sistemática de la evidencia, y sus afirmaciones respecto a las aplicaciones emergentes siguen siendo especulativas pendientes de validación clínica; el resumen también señala que los perfiles de seguridad y complicaciones siguen siendo controvertidos.
Citación
Leech therapeutic applications.
Abdualkader A et al. · Indian journal of pharmaceutical sciences, 2013
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: June 18, 2026